Showing results (951-960 of 1,075) with videos related to

Sort By:
Pageof 108
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2022
Permanent pacemaker implantation and left bundle branch block with self-expanding valves - a SCOPE 2 subanalysisCostanza Pellegrini, Philippe Garot, Marie-Claude Morice, et al.
The American Journal of Cardiology|March 24, 2015
Meta-analysis of randomized controlled trials and adjusted observational results of use of clopidogrel, aspirin, and oral anticoagulants in patients undergoing percutaneous coronary interventionFabrizio D'Ascenzo, Salma Taha, Claudio Moretti, et al.
American Heart Journal|February 24, 2024
Strategy to optimize PeriproCeduraL AnticOagulation in structural transseptal interventions: Design and rationale of the STOP CLOT trialJerzy Pręgowski, Radosław Pracoń, Aleksandra Mioduszewska, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 13, 2016
Impact of overlapping on 1-year clinical outcomes in patients undergoing everolimus-eluting bioresorbable scaffolds implantation in routine clinical practice: Insights from the European multicenter GHOST-EU registryLuis Ortega-Paz, Davide Capodanno, Giuseppe Giacchi, et al.
JAMA Cardiology|June 1, 2022
Efficacy and Safety Considerations With Dose-Reduced Direct Oral Anticoagulants: A ReviewBehnood Bikdeli, Farbod Zahedi Tajrishi, Parham Sadeghipour, et al.
Journal of the American Heart Association|February 14, 2022
CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention in Diverse Clinical SettingsAmber L Beitelshees, Cameron D Thomas, Philip E Empey, et al.
JAMA Cardiology|May 15, 2021
Sex Differences Among Patients With High Risk Receiving Ticagrelor With or Without Aspirin After Percutaneous Coronary Intervention: A Subgroup Analysis of the TWILIGHT Randomized Clinical TrialBirgit Vogel, Usman Baber, David J Cohen, et al.
Plos One|December 30, 2022
One-year cardiovascular outcomes after coronavirus disease 2019: The cardiovascular COVID-19 registryLuis Ortega-Paz, Victor Arévalos, Diego Fernández-Rodríguez, et al.
European Heart Journal|July 12, 2018
Standardized classification and framework for reporting, interpreting, and analysing medication non-adherence in cardiovascular clinical trials: a consensus report from the Non-adherence Academic Research Consortium (NARC)Marco Valgimigli, Hector M Garcia-Garcia, Bernard Vrijens, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|October 17, 2024
Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trialUsman Baber, Davide Cao, Timothy Collier, et al.
Pageof 108